M. Ponchant

551 total citations
21 papers, 435 citations indexed

About

M. Ponchant is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmaceutical Science. According to data from OpenAlex, M. Ponchant has authored 21 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 6 papers in Pharmaceutical Science. Recurrent topics in M. Ponchant's work include Neuroscience and Neuropharmacology Research (7 papers), Chemical Reactions and Isotopes (6 papers) and Receptor Mechanisms and Signaling (5 papers). M. Ponchant is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Chemical Reactions and Isotopes (6 papers) and Receptor Mechanisms and Signaling (5 papers). M. Ponchant collaborates with scholars based in France and United States. M. Ponchant's co-authors include H. Gozlan, M. Hamon, Daniel Vergé, Anne‐Marie Laporte, C. Crouzel, Stéphane Demphel, Françoise Hinnen, Philippe Hantraye, Maria-João Ribeiro and Marc Peschanski and has published in prestigious journals such as Journal of Neurochemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

M. Ponchant

21 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Ponchant France 9 246 185 90 63 61 21 435
Dimitri Roumenov France 9 185 0.8× 210 1.1× 35 0.4× 44 0.7× 27 0.4× 9 431
R. Marwood United States 7 265 1.1× 293 1.6× 34 0.4× 20 0.3× 93 1.5× 9 440
Hayden T. Ravert United States 8 225 0.9× 163 0.9× 16 0.2× 115 1.8× 22 0.4× 8 370
Daniel Sohn Sweden 9 132 0.5× 111 0.6× 27 0.3× 36 0.6× 79 1.3× 13 310
M P Kung United States 9 223 0.9× 174 0.9× 45 0.5× 73 1.2× 15 0.2× 14 372
Frederik C. Grønvald Denmark 8 314 1.3× 230 1.2× 36 0.4× 25 0.4× 26 0.4× 10 420
Felix Neumaier Germany 10 87 0.4× 149 0.8× 24 0.3× 67 1.1× 37 0.6× 48 340
Caroline Papin United States 13 191 0.8× 278 1.5× 126 1.4× 117 1.9× 53 0.9× 30 607
Zhi-Ying Yang United States 7 244 1.0× 126 0.7× 34 0.4× 126 2.0× 11 0.2× 8 455
J.‐L. PEGLION France 10 321 1.3× 258 1.4× 28 0.3× 11 0.2× 61 1.0× 17 627

Countries citing papers authored by M. Ponchant

Since Specialization
Citations

This map shows the geographic impact of M. Ponchant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ponchant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ponchant more than expected).

Fields of papers citing papers by M. Ponchant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Ponchant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ponchant. The network helps show where M. Ponchant may publish in the future.

Co-authorship network of co-authors of M. Ponchant

This figure shows the co-authorship network connecting the top 25 collaborators of M. Ponchant. A scholar is included among the top collaborators of M. Ponchant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Ponchant. M. Ponchant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ribeiro, Maria-João, Marie Vidailhet, Christian Loc’h, et al.. (2002). Dopaminergic Function and Dopamine Transporter Binding Assessed With Positron Emission Tomography in Parkinson Disease. Archives of Neurology. 59(4). 580–580. 105 indexed citations
2.
Dollé, Frédéric, Françoise Hinnen, Françoise Vaufrey, et al.. (2001). Highly efficient synthesis of [11C]Me‐QNB, a selective radioligand for the quantification of the cardiac muscarinic receptors using PET. Journal of Labelled Compounds and Radiopharmaceuticals. 44(5). 337–345. 6 indexed citations
3.
Ponchant, M., et al.. (2000). [Tetrazoyl-11C]LY202157 synthesis forin vivo studies of the NMDA receptor channel complex. Journal of Labelled Compounds and Radiopharmaceuticals. 43(13). 1311–1320. 3 indexed citations
4.
5.
Ponchant, M., Stéphane Demphel, Françoise Hinnen, & C. Crouzel. (1997). Radiosynthesis of [tetrazoyl-11C]irbesartan, a non-peptidic angiotensin II antagonist. European Journal of Medicinal Chemistry. 32(9). 747–752. 6 indexed citations
6.
Ponchant, M., et al.. (1996). Synthesis of a dopamine uptake inhibitor for PET studies: 1-[1-(2-benzo(b)thiophenyl)cyclohexyl]-4-(2-[18F]fluoroethyl) piperazine. Journal of Labelled Compounds and Radiopharmaceuticals. 38(3). 299–308. 3 indexed citations
7.
Ponchant, M., et al.. (1994). Synthesis of [3′,5′-3H2]-α-fluoromethyl-tyrosine as a radioactive specific label of rat brain tyrosine hydroxylase. Bioorganic & Medicinal Chemistry. 2(8). 827–835. 9 indexed citations
8.
Ponchant, M., et al.. (1993). Synthesis of 3-[18F]fluoromethyl-BTCP and evaluation as a potential PET radioligand for the dopamine transporter in baboons. Nuclear Medicine and Biology. 20(6). 727–733. 9 indexed citations
9.
10.
Ponchant, M., et al.. (1992). Synthesis of 3‐[18F]‐fluoromethyl‐TCP1, A potential tool for pet study of the nmda receptor channel complex. Journal of Labelled Compounds and Radiopharmaceuticals. 31(11). 955–960. 9 indexed citations
11.
Chicheportiche, Robert, et al.. (1992). Binding Properties of 3‐[125I]Iodophencyclidine, a New Radioligand for N‐Methyl‐D‐Aspartate‐Gated Ionic Channels. Journal of Neurochemistry. 59(2). 492–499. 2 indexed citations
12.
Boireau, Alain, et al.. (1992). [3H]RP 62203, a ligand of choice to label in vivo brain 5-HT2 receptors. European Journal of Pharmacology. 216(1). 53–57. 12 indexed citations
13.
Ponchant, M., et al.. (1991). Synthesis of 5‐[125I]‐iodo‐zacopride, a new probe for 5‐HT3 receptor binding sites. Journal of Labelled Compounds and Radiopharmaceuticals. 29(10). 1147–1155. 8 indexed citations
14.
Ponchant, M., et al.. (1990). [(125I)iodo-zacopride: new ligand for the study by autoradiography of central 5-HT3 receptors].. PubMed. 311(6). 231–7. 4 indexed citations
15.
Ponchant, M., et al.. (1990). Synthesis of 3‐[125I]‐iodo‐phencyclidine for biological studies. Journal of Labelled Compounds and Radiopharmaceuticals. 28(9). 1059–1064. 5 indexed citations
16.
Ponchant, M., et al.. (1990). Synthesis and biological activity of iodinated and photosensitive derivatives of tetrabenazine. European Journal of Medicinal Chemistry. 25(4). 369–374. 5 indexed citations
17.
Mestikawy, Salah El, Delphine Taussig, H. Gozlan, et al.. (1989). Chromatographic Analyses of the Serotonin 5‐HT1A Receptor Solubilized from the Rat Hippocampus. Journal of Neurochemistry. 53(5). 1555–1566. 18 indexed citations
18.
Gozlan, H., M. Ponchant, G. Daval, et al.. (1988). 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.. Journal of Pharmacology and Experimental Therapeutics. 244(2). 751–759. 40 indexed citations
19.
Ponchant, M., et al.. (1988). [125I-BH-8-MeO-N-PAT, a new ligand for the study of 5-HT1A receptors in the central nervous system].. PubMed. 306(4). 147–52. 4 indexed citations
20.
Guillaumet, Gérald, G. Coudert, M. Ponchant, J. P. Beaucourt, & L. Pichat. (1984). Synthese d'un Antagoniste Alpha Adrenergique Marque au Tritium: WB 4101 [benzodioxanyl‐1,4‐3H‐2,3], ou N‐[dimethoxy‐2,6 phenoxyethyl] aminomethyl‐2 benzodioxanne‐1,4[3H‐2,3]. Journal of Labelled Compounds and Radiopharmaceuticals. 21(2). 161–172. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitri Roumenov Breakdown of academic impact, for papers by R. Marwood Breakdown of academic impact, for papers by Hayden T. Ravert Breakdown of academic impact, for papers by Daniel Sohn Breakdown of academic impact, for papers by M P Kung Breakdown of academic impact, for papers by Frederik C. Grønvald Breakdown of academic impact, for papers by Felix Neumaier Breakdown of academic impact, for papers by Caroline Papin Breakdown of academic impact, for papers by Zhi-Ying Yang Breakdown of academic impact, for papers by J.‐L. PEGLION
Rankless by CCL
2026